Management of side effects of sirolimus therapy

Sirolimus (SRL) has been shown to improve long-term graft survival in several calcineurin inhibitor avoidance/minimization protocols. Although SRL has been suggested to reduce the progression of chronic renal graft damage and to prevent the development of neoplasia, two of the most prominent challen...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplantation 2009-04, Vol.87 (8 Suppl), p.S23-S26
Hauptverfasser:	Stallone, Giovanni, Infante, Barbara, Grandaliano, Giuseppe, Gesualdo, Loreto
Format:	Artikel
Sprache:	eng
Schlagworte:	Anemia - chemically induced Diabetes Mellitus - chemically induced Diabetes Mellitus - pathology Glucose Intolerance - chemically induced Glucose Intolerance - pathology Humans Immunosuppressive Agents - adverse effects Immunosuppressive Agents - therapeutic use Kidney - drug effects Kidney - pathology Kidney Transplantation - adverse effects Kidney Transplantation - immunology Kidney Transplantation - pathology Lymphocele - chemically induced Lymphocele - pathology Proteinuria - chemically induced Proteinuria - pathology Sirolimus - adverse effects Sirolimus - therapeutic use Wound Healing - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!